| Literature DB >> 32490419 |
Karen Brage1,2, John Hjarbaek3, Eleanor Boyle1, Kim Gordon Ingwersen4, Per Kjaer1,2, Birgit Juul-Kristensen1.
Abstract
BACKGROUND: We aimed to explore the discriminative validity of ultrasound strain elastography (SEL) between patients with painful supraspinatus tendinopathy and healthy control shoulders, as well as the associations between SEL and magnetic resonance imaging (MRI), conventional ultrasound (tendon thickness), and the Disabilities of the Arm, Shoulder and Hand questionnaire (DASH).Entities:
Keywords: Strain elastography; rotator cuff; supraspinatus tendon; tendinopathy; tendinosis; tendon quality; ultrasound; validity
Year: 2020 PMID: 32490419 PMCID: PMC7256788 DOI: 10.1016/j.jseint.2019.12.008
Source DB: PubMed Journal: JSES Int ISSN: 2666-6383
Figure 1Strain elastography and conventional ultrasound (tendon thickness) were performed while the participant was sitting in a custom-made chair with the selected upper limb fixed in a standardized position.
Figure 2The reference bar (left) indicates that soft tissue (s) is shown in red whereas stiff or hard tissue (h) is shown in blue. Imaging showed an asymptomatic and homogeneously blue (and stiff) supraspinatus tendon (middle) and a symptomatic supraspinatus tendon (right), with green, yellow, and red areas indicating signs of softening.
Demographic data for patients with supraspinatus tendinopathy and healthy control shoulders (N = 60)
| Variable | Patients (n = 30) | Controls (n = 30) |
|---|---|---|
| Age, yr | 51 (10.3) | 47 (5.0) |
| Women, n (%) | 17 (56.7) | 21 (70.0) |
| BMI | 26.76 (5.09) | 24.39 (4.73) |
| Duration of symptoms, mo | 9.5 (17.25) | — |
| Dominant arm scanned, n (%) | 18 (60.0) | 14 (46.7) |
| Workload, present occupation (0-10 [in which 10 indicates very physically heavy]) | 5 (5) | 3 (4) |
| Work ability (0-10 [in which 10 indicates very high]) | 8 (4) | 10 (1) |
| Corticosteroid injection (within past 6 wk), n (%) | 4 (13.3) | 0 (0.0) |
| Symptom history, n (%) | ||
| Accident or acute incidence | 5 (16.7) | — |
| Slow consistent development (overload) | 13 (43.3) | — |
| Unknown | 12 (40) | — |
| Pain intensity: VAS score | ||
| Rest (0-100) | 30.0 (36.8) | 0.0 (0.0) |
| Activity (0-100) | 58.0 (20.5) | 0.0 (0.0) |
| Sleep (0-100) | 50.5 (32.5) | 0.0 (0.0) |
| Maximum (0-100) | 78.5 (14.8) | 0.0 (0.0) |
| DASH score | 31.5 (16.0) | 0.0 (2.0) |
| EQ-5D-3L, n (%) | ||
| Mobility problems | 2 (6.7) | 0 (0.0) |
| Self-care problems | 10 (33.3) | 0 (0.0) |
| Usual activities problems | 24 (80.0) | 0 (0.0) |
| Pain/discomfort problems | 30 (100.0) | 0 (0.0) |
| Anxiety problems | 4 (13.3) | 0 (0.0) |
| EQ-VAS (0-100) | 60 (72.0) | 95 (30.5) |
| MRI (grade), n (%) | ||
| 0: normal | 0 (0.0) | 12 (40.0) |
| 1: mild tendinopathy | 11 (36.7) | 11 (36.7) |
| 2: moderate tendinopathy | 16 (53.3) | 4 (13.3) |
| 3: severe tendinopathy | 2 (6.7) | 0 (0.0) |
| Tendon thickness (UL), mean ± SD, mm | 7.76 ± 1.11 | 7.48 ± 1.02 |
BMI, body mass index; VAS, visual analog scale (0-100); DASH, Disabilities of the Arm, Shoulder and Hand questionnaire (0-100); EQ-5D-3L, quality of life by health dimension; EQ-VAS, quality of life (0-100); MRI, magnetic resonance imaging; SD, standard deviation; UL, conventional ultrasound.
Data are presented as median (interquartile range) unless otherwise indicated.
The group comprised 27 patients (as 3 patients were not employed).
The group comprised 29 patients (as 1 control was not employed).
Three controls did not undergo magnetic resonance imaging scans.
Descriptive values of strain elastography variables for raw values, deltoid ratio, color rating, and number of red/yellow lesions for patients with supraspinatus tendinopathy and healthy control shoulders (N = 60)
| Variable | Patients (n = 30) | Controls (n = 30) | Difference |
|---|---|---|---|
| Raw values | |||
| Middle tendon part | 3.42 ± 0.81 | 3.68 ± 0.73 | –0.26 |
| Worst tendon part | 3.10 ± 0.68 | 3.39 ± 0.66 | –0.29 |
| Total tendon | 3.55 ± 0.66 | 3.75 ± 0.61 | –0.21 |
| Deltoid ratio (tendon-deltoid muscle) | |||
| Middle tendon part | 11.30 ± 4.07 | 12.59 ± 4.11 | –1.56 |
| Worst tendon part | 10.25 ± 3.32 | 11.58 ± 3.41 | –1.33 |
| Total tendon | 11.69 ± 3.64 | 12.81 ± 3.50 | –1.12 |
| Color rating, n (%) | |||
| Middle tendon part | |||
| <10% not blue (hardest tissue) | 10 (33.3) | 13 (43.3) | –10 |
| 10%-25% not blue | 11 (36.7) | 8 (26.7) | –3 |
| 26%-50% not blue than blue | 4 (13.3) | 6 (20) | 2 |
| >50% not blue (softest tissue) | 5 (16.7) | 3 (10) | –2 |
| Worst tendon part | |||
| <10% not blue (hardest tissue) | 5 (16.7) | 11 (36.7) | 6 |
| 10%-25% not blue | 11 (36.7) | 7 (23.3) | –4 |
| 26%-50% not blue | 4 (13.3) | 9 (30) | 5 |
| >50% not blue (softest tissue) | 10 (33.3) | 3 (10) | –7 |
| Total tendon | |||
| <10% not blue (hardest tissue) | 5 (16.7) | 10 (33.3) | 5 |
| 10%-25% not blue | 13 (43.3) | 5 (16.7) | –8 |
| 26%-50% not blue | 6 (20) | 9 (30) | 3 |
| >50% not blue (softest tissue) | 6 (20) | 6 (20) | 0 |
| No. of red/yellow lesions (%) | |||
| Middle tendon third | |||
| 0 | 22 (73.3) | 21 (70) | –1 |
| 1 | 4 (13.3) | 6 (20) | 2 |
| 2 | 2 (6.7) | 2 (6.7) | 0 |
| ≥3 | 2 (6.7) | 1 (3.3) | –1 |
| Worst tendon part | |||
| 0 | 9 (30) | 14 (46.7) | 5 |
| 1 | 12 (40) | 8 (26.7) | –4 |
| 2 | 6 (20) | 5 (16.7) | –1 |
| ≥3 | 3 (10) | 3 (10) | 0 |
| Total tendon | |||
| 0 | 10 (33.3) | 14 (46.7) | 4 |
| 1 | 10 (33.3) | 6 (20) | –4 |
| 2 | 6 (20) | 5 (16.7) | –1 |
| ≥3 | 4 (13.3) | 5 (16.7) | 1 |
Data are presented as mean ± standard deviation for raw values, median (interquartile range) for deltoid ratio, and count (percentage) for color rating and number of red/yellow lesions. Raw values comprise raw elastography data, and the deltoid ratio is defined as the ratio between the supraspinatus tendon and a soft area in the deltoid muscle.
Discriminative validity (associations) with OR for patients having supraspinatus tendinopathy for strain elastography variables in unadjusted and adjusted models (for sex and BMI) for patients with supraspinatus tendinopathy and healthy control shoulders (N = 60)
| Variable | OR (95% CI) | |
|---|---|---|
| Unadjusted model | Adjusted model | |
| Continuous scale | ||
| Raw values | ||
| Middle tendon part | 1.578 (0.795-3.131) | 3.978 (1.414-11.197) |
| Worst tendon part | 1.931 (0.856-13.788) | 4.602 (1.536-13.788) |
| Total tendon | 1.716 (0.743-3.966) | 4.865 (1.406-16.836) |
| Deltoid ratio | ||
| Middle tendon part | 1.086 (0.948-1.244) | 1.188 (1.000-1.411) |
| Worst tendon part | 1.134 (0.960-1.340) | 1.260 (1.027-1.545) |
| Total tendon | 1.097 (0.943-1.277) | 1.203 (0.995-1.454) |
| Dichotomous scale | ||
| Color rating (≥26% color other than blue [soft] vs. <26% color other than blue [hard]) | ||
| Middle tendon part | 1.179 (0.383-3.629) | 1.675 (0.485-5.783) |
| Worst tendon part | 0.875 (0.318-2.410) | 1.521 (0.470-4.922) |
| Total tendon | 1.00 (0.356-2.809) | 1.408 (0.455-4.358) |
| No. of red/yellow lesions (having lesions vs. not having lesions) | ||
| Middle tendon part | 0.848 (0.276-2.612) | 1.100 (0.333-3.635) |
| Worst tendon part | 2.042 (0.707-5.895) | 3.484 (0.970-12.517) |
| Total tendon | 2.698 (0.804-9.060) | 2.698 (0.804-9.060) |
OR, odds ratio; BMI, body mass index; CI, confidence interval.
Raw values comprise raw elastography data, and the deltoid ratio is defined as the ratio between the supraspinatus tendon and a soft area in the deltoid muscle.
Significant difference.
Convergent validity (associations) with OR for patients having softening of tendon with linear regression between strain elastography variables (raw values and deltoid ratio) for having softening of tendon and DASH score, MRI (binary), and tendon thickness (conventional ultrasound) in unadjusted and adjusted models (for sex and BMI) for patients with supraspinatus tendinopathy and healthy control shoulders (N = 60)
| Outcome variable (continuous scale) | Independent variable | Unadjusted model | Adjusted model | ||
|---|---|---|---|---|---|
| Regression coefficient, β (95% CI) | Regression coefficient, β (95% CI) | ||||
| Raw values | |||||
| Middle tendon part | MRI | 0.39 (–0.11 to 0.88) | .12 | 0.70 (0.29 to 1.11) | <.01 |
| Worst tendon part | MRI | 0.40 (–0.05 to 0.84) | .08 | 0.66 (0.27 to 1.05) | <.01 |
| Total tendon | MRI | 0.32 (–0.74 to 0.90) | .12 | 0.58 (0.24 to 0.93) | <.01 |
| Middle tendon part | Tendon thickness | 0.02 (–0.03 to 0.04) | .12 | 0.01 (0.02 to 0.01) | .60 |
| Worst tendon part | Tendon thickness | 0.01 (–0.03 to 0.01) | .26 | 0.00 (0.02 to 0.02) | .86 |
| Total tendon | Tendon thickness | –0.01 (–0.02 to 0.01) | .34 | 0.00 (–0.02 to 0.01) | .95 |
| Middle tendon part | DASH | 0.01 (–0.00 to 0.02) | .17 | 0.01 (0.00 to 0.02) | .02 |
| Worst tendon part | DASH | 0.01 (–0.00 to 0.02) | .14 | 0.01 (0.00 to 0.02) | .02 |
| Total tendon | DASH | 0.01 (–0.00 to 0.01) | .24 | 0.01 (0.00 to 0.02) | .04 |
| Deltoid ratio | |||||
| Middle tendon part | MRI | 0.61 (–2.17 to 3.38) | .66 | 1.85 (–0.69 to 4.39) | .15 |
| Worst tendon part | MRI | 0.69 (–1.59 to 2.97) | .55 | 1.70 (–0.42 to 3.81) | .11 |
| Total tendon | MRI | 0.42 (–2.00 to 2.85) | .73 | 1.47 (–0.72 to 3.67) | .18 |
| Middle tendon part | Tendon thickness | –0.05 (–0.15 to 0.05) | .36 | –0.01 (–0.11 to 0.08) | .77 |
| Worst tendon part | Tendon thickness | –0.03 (–0.11 to 0.06) | .52 | –0.00 (–0.08 to 0.08) | .98 |
| Total tendon | Tendon thickness | –0.02 (–0.11 to 0.07) | .62 | 0.01 (–0.08 to 0.09) | .94 |
| Middle tendon part | DASH | 0.04 (–0.02 to 0.10) | .21 | 0.05 ( 0.00 to 0.10) | .07 |
| Worst tendon part | DASH | 0.03 (–0.02 to 0.08) | .17 | 0.04 (–0.00 to 0.09) | .06 |
| Total tendon | DASH | 0.03 (–0.02 to 0.10) | .52 | 0.04 (–0.01 to 0.08) | .10 |
DASH, Disabilities of the Arm, Shoulder and Hand questionnaire (0-100); MRI, magnetic resonance imaging (dichotomous scale); BMI, body mass index; CI, confidence interval.
Raw values comprise raw elastography data, and the deltoid ratio is defined as the ratio between the supraspinatus tendon and a soft area in the deltoid muscle.
Significant difference.
Convergent validity (associations) with OR for patients having soft tendon between strain elastography variables (color ratings and number of red/yellow lesions) and DASH score, MRI, and tendon thickness (conventional ultrasound) in unadjusted and adjusted models (potential confounders of sex and BMI) for patients with supraspinatus tendinopathy and healthy control shoulders (N = 60)
| Outcome variable (dichotomous scale) | Independent variable | OR (95% CI) | |
|---|---|---|---|
| Unadjusted model | Adjusted model | ||
| Color ratings (≥26% color other than blue [soft] vs. <26% color other than blue [stiff]) | |||
| Middle tendon part | MRI | 0.18 (0.02-1.50) | 0.10 (0.01-1.00) |
| Worst tendon part | MRI | 0.65 (0.18-2.37) | 0.28 (0.06-1.30) |
| Total tendon | MRI | 0.40 (0.10-1.68) | 0.23 (0.05-1.12) |
| Middle tendon part | Tendon thickness | 0.92 (0.86-1.00) | 0.92 (0.85-1.00) |
| Worst tendon part | Tendon thickness | 0.98 (0.93-1.02) | 0.99 (0.95-1.06) |
| Total tendon | Tendon thickness | 0.97 (0.92-1.02) | 0.98 (0.93-1.04) |
| Middle tendon part | DASH | 0.99 (0.96-1.02) | 0.99 (0.96-1.03) |
| Worst tendon part | DASH | 0.99 (0.96-1.02) | 1.00 (0.97-1.03) |
| Total tendon | DASH | 1.00 (0.97-1.03) | 1.00 (0.98-1.03) |
| No. of red/yellow lesions (having lesions vs. not having lesions) | |||
| Middle tendon part | MRI | 0.80 (0.19-3.42) | 0.57 (0.12-2.66) |
| Worst tendon part | MRI | 0.72 (0.20-2.67) | 0.43 (0.10-1.88) |
| Total tendon | MRI | 0.80 (0.22-2.94) | 0.51 (0.12-2.16) |
| Middle tendon part | Tendon thickness | 0.96 (0.90-1.01) | 0.96 (0.90-1.03) |
| Worst tendon part | Tendon thickness | 0.99 (0.95-1.04) | 1.01 (0.96-1.06) |
| Total tendon | Tendon thickness | 1.00 (0.95-1.05) | 1.01 (0.96-1.07) |
| Middle tendon part | DASH | 1.00 (0.97-1.03) | 1.00 (0.97-1.03) |
| Worst tendon part | DASH | 0.98 (0.95-1.05) | 1.03 (0.10-1.07) |
| Total tendon | DASH | 0.98 (0.95-1.05) | 1.03 (0.99-1.06) |
DASH, Disabilities of the Arm, Shoulder and Hand questionnaire (0-100); MRI, magnetic resonance imaging (dichotomous scale); BMI, body mass index; OR, odds ratio; CI, confidence interval.